Allspring Global Investments Holdings LLC Has $25.31 Million Stock Position in Integer Holdings Co. (NYSE:ITGR)

Allspring Global Investments Holdings LLC lowered its position in shares of Integer Holdings Co. (NYSE:ITGR) by 9.3% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 194,678 shares of the medical equipment provider’s stock after selling 20,077 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.58% of Integer worth $25,308,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of ITGR. Contravisory Investment Management Inc. boosted its position in Integer by 55.9% during the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 80 shares during the last quarter. Quest Partners LLC raised its stake in shares of Integer by 3,688.9% during the 2nd quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 332 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of Integer by 60.9% during the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock worth $43,000 after purchasing an additional 142 shares in the last quarter. Headlands Technologies LLC bought a new stake in shares of Integer during the 1st quarter worth approximately $106,000. Finally, Innealta Capital LLC bought a new stake in shares of Integer during the 2nd quarter worth approximately $110,000. Institutional investors and hedge funds own 99.29% of the company’s stock.

Wall Street Analyst Weigh In

ITGR has been the topic of a number of analyst reports. Benchmark upped their price objective on Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday. Citigroup upped their price objective on Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 1st. Oppenheimer started coverage on Integer in a research note on Tuesday, July 16th. They set an “outperform” rating and a $135.00 price objective on the stock. KeyCorp increased their price target on Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a research note on Tuesday, October 15th. Finally, Truist Financial increased their price target on Integer from $145.00 to $150.00 and gave the company a “buy” rating in a research note on Monday, October 14th. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $140.14.

Insiders Place Their Bets

In other Integer news, Director Jean M. Hobby sold 11,960 shares of the stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the transaction, the director now owns 2,280 shares in the company, valued at $272,824.80. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 2.00% of the company’s stock.

Integer Stock Up 0.8 %

ITGR stock opened at $126.53 on Thursday. The company has a debt-to-equity ratio of 0.73, a current ratio of 3.29 and a quick ratio of 1.96. The stock has a market capitalization of $4.24 billion, a price-to-earnings ratio of 43.78, a PEG ratio of 1.86 and a beta of 1.08. The business’s fifty day moving average price is $127.37 and its two-hundred day moving average price is $120.86. Integer Holdings Co. has a fifty-two week low of $69.40 and a fifty-two week high of $133.53.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.06. The firm had revenue of $436.20 million for the quarter, compared to analysts’ expectations of $437.00 million. Integer had a return on equity of 11.48% and a net margin of 6.31%. The company’s quarterly revenue was up 9.0% compared to the same quarter last year. During the same quarter last year, the business earned $1.14 EPS. On average, equities analysts anticipate that Integer Holdings Co. will post 5.3 earnings per share for the current year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.